---
name: SaaS-cells Deep×2→Fresh×2 cross-review (per-point, late round)
description: 2026-05-13 — per-point Deep response to Fresh×2; 0 CHALLENGE bidirectional, 4 severity-floor SYNTHESIZE, 7 Fresh-unique adoptions (notably SLO absence as new HIGH, write-latency regression as standalone CRITICAL), 14 Deep-unique persistent governance/option-value items
type: project
originSessionId: eedd4da5-196e-4eeb-bf76-5a71b4d87b7d
---
Per-point Deep×2 response to Fresh×2 on SaaS cell-based multi-region proposal.

**Verdict (stable across 11+ rounds):** Do not approve as written. Recuse-of-three. Decompose into separable decisions. ~$50K/0.5-FTE counter-proposal (PG read replica in eu-west, PgBouncer, query observability, runbooks, growth instrumentation).

**Bidirectional convergence:**
- 0 strict CHALLENGEs in either direction.
- ~85% issue overlap.

**Severity-floor escalations (SYNTHESIZE):**
- F1-14 (10M target MED → HIGH; investment-grade speculation)
- F2-12 (weekend-retreat process MED → HIGH; load-bearing because authors=approvers w/ stacked COI)
- F1-6 standalone CRITICAL (CRDB cross-region Raft regresses cited-healthy 38ms write metric to 100–300ms — proposal makes worse what is currently fine)
- F2-11 lock-in-before-knowing-constraints → HIGH

**Fresh-unique catches to adopt (7):**
1. F2-14: No stated SLO/SLA driving the change — NEW HIGH not in Deep's 38-issue list
2. F2-15: "Series-A fails from PMF/runway, not infra that can't scale to 10M users they don't have" — adopt as executive-summary sentence
3. F1-17: Existing deploy-bug incident class scales adversely with proposed deploy complexity
4. F2-2: Hiring pipeline for 5 senior platform eng (cell+Istio+CRDB intersection) would dominate next year by itself
5. F2-1: Platform spend likely exceeds revenue framing (concrete > runway-months)
6. F1-5: CRDB serializable forces retry loops; 8 PG-idiom engineers will produce latent retry bugs
7. F1-6 as CRITICAL: write-latency regression on the only cited-healthy DB metric

**Deep-unique persistent items Fresh missed both sessions (14):**
Recusal-of-three (vs "more voices"), 4-vector COI named, coercive rhetoric H12, no reverse off-ramp H8, CRDB licensing tier risk H11, cell sharding-key irreversibility H14, mesh↔CRDB debugging compounding M13, customer SLA mismatch M9, CDN already absorbs geo M12, PG p99 38ms refutes "PG can't scale" M14, option-value M15, ap-northeast unjustified L1, 8-cells/region underived L2, NIH pattern L3.

**Pattern (rounds 1–11 stable):** Fresh sharpens consequence-chain framing; Deep catches governance/COI/option-value/sequencing items Fresh under-rates.

**Calibration call: stop iterating.** Technical question settled. Remaining unresolved question — will the three authors recuse — is organisational, not architectural; not addressable by more reviewer rounds.
